Physical activity, fitness, and vascular health in patients with asthma

High levels of the proinflammatory cytokines IL-6, C-reactive protein, and tumor necrosis factor-alpha are elevated in asthma, and all are associated with increased CVD risk.2,3 Reduced endothelial vasodilation is seen in early stages of CVD development and is predictive of CVD.4 Patients with asthm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2015-09, Vol.136 (3), p.809-811.e3
Hauptverfasser: Moore, Linn E., BSc, Bhutani, Mohit, MD, Petersen, Stewart R., PhD, McMurtry, M. Sean, MD, PhD, Byers, Bradley W., BSc, Tedjasaputra, Vincent, MSc, Stickland, Michael K., PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 811.e3
container_issue 3
container_start_page 809
container_title Journal of allergy and clinical immunology
container_volume 136
creator Moore, Linn E., BSc
Bhutani, Mohit, MD
Petersen, Stewart R., PhD
McMurtry, M. Sean, MD, PhD
Byers, Bradley W., BSc
Tedjasaputra, Vincent, MSc
Stickland, Michael K., PhD
description High levels of the proinflammatory cytokines IL-6, C-reactive protein, and tumor necrosis factor-alpha are elevated in asthma, and all are associated with increased CVD risk.2,3 Reduced endothelial vasodilation is seen in early stages of CVD development and is predictive of CVD.4 Patients with asthma have reduced endothelial function and increased arterial stiffness than do those without asthma.5,6 Systemic inflammation impairs endothelial function7 and increases arterial stiffness,8 but it is unknown whether there is a connection between systemic inflammation, vascular function, and arterial stiffness in subjects with asthma. Characteristic Control Asthma P value (2-tailed) Sample size, n (male/female) 16 (8/8) 16 (10/6) .72 Age (y) 26.6 ± 5.2 27.8 ± 6.1 .58 BMI (kg/m2) 24.7 ± 3.5 24.6 ± 4.6 .96 FEV1 prebronchodilator (% predicted) 96.3 ± 12.1 81.3 ± 15.1 .004 FEV1 postbronchodilator (% predicted) 100.9 ± 13.2 91.6 ± 12.6 .051 Feno (ppb) 17.9 ± 8.5 37.3 ± 40.9 .16 Asthma Control Questionnaire score 0.1 ± 0.2 1.0 ± 0.4
doi_str_mv 10.1016/j.jaci.2015.02.033
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1710654397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674915003395</els_id><sourcerecordid>1710654397</sourcerecordid><originalsourceid>FETCH-LOGICAL-c553t-9518381d9bbf6f12c673b525964acab9be0a68b26e73f72d23bb654daa044c5d3</originalsourceid><addsrcrecordid>eNp9kV2L1DAUhoMo7rj6B7yQgjdebLv5aNIGRJBF14UFF9TrcJKeMqmddkzSkfn3psyqsBd7FRKe93DyvIS8ZrRilKnLoRrA-YpTJivKKyrEE7JhVDelarl8SjaUalaqptZn5EWMA8130ern5IxLzQSjYkOu77bH6B2MBbjkDz4dL4repwljvChg6ooDRLeMEIotwpi2hZ-KPSSPU4rFb58fIKbtDl6SZz2MEV_dn-fkx-dP36--lLdfr2-uPt6WTkqRSi1ZK1rWaWt71TPuVCOszOuoGhxYbZGCai1X2Ii-4R0X1ipZdwC0rp3sxDl5d5q7D_OvBWMyOx8djiNMOC_RsIbRHBC6yejbB-gwL2HK22WKal4zVatM8RPlwhxjwN7sg99BOBpGzarZDGbVbFbNhnKTNefQm_vRi91h9y_y12sG3p8AzC4OHoOJLjtz2PmALplu9o_P__Ag7kY_rTX9xCPG__8wMQfMt7XotWcmaY5rKf4Ar2WhmA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1709241646</pqid></control><display><type>article</type><title>Physical activity, fitness, and vascular health in patients with asthma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Moore, Linn E., BSc ; Bhutani, Mohit, MD ; Petersen, Stewart R., PhD ; McMurtry, M. Sean, MD, PhD ; Byers, Bradley W., BSc ; Tedjasaputra, Vincent, MSc ; Stickland, Michael K., PhD</creator><creatorcontrib>Moore, Linn E., BSc ; Bhutani, Mohit, MD ; Petersen, Stewart R., PhD ; McMurtry, M. Sean, MD, PhD ; Byers, Bradley W., BSc ; Tedjasaputra, Vincent, MSc ; Stickland, Michael K., PhD</creatorcontrib><description>High levels of the proinflammatory cytokines IL-6, C-reactive protein, and tumor necrosis factor-alpha are elevated in asthma, and all are associated with increased CVD risk.2,3 Reduced endothelial vasodilation is seen in early stages of CVD development and is predictive of CVD.4 Patients with asthma have reduced endothelial function and increased arterial stiffness than do those without asthma.5,6 Systemic inflammation impairs endothelial function7 and increases arterial stiffness,8 but it is unknown whether there is a connection between systemic inflammation, vascular function, and arterial stiffness in subjects with asthma. Characteristic Control Asthma P value (2-tailed) Sample size, n (male/female) 16 (8/8) 16 (10/6) .72 Age (y) 26.6 ± 5.2 27.8 ± 6.1 .58 BMI (kg/m2) 24.7 ± 3.5 24.6 ± 4.6 .96 FEV1 prebronchodilator (% predicted) 96.3 ± 12.1 81.3 ± 15.1 .004 FEV1 postbronchodilator (% predicted) 100.9 ± 13.2 91.6 ± 12.6 .051 Feno (ppb) 17.9 ± 8.5 37.3 ± 40.9 .16 Asthma Control Questionnaire score 0.1 ± 0.2 1.0 ± 0.4 &lt;.001 Allergies (% yes) 18.8 57.1 .03 SABA usage (%) 0.0 56.3 &lt;.001 ICS usage (%) 0.0 18.8 &lt;.001 Combination ICS + LABA usage (%) 0.0 43.8 &lt;.001 Physical activity, steps/d 10,711 ± 2,675 11,125 ± 5,487 .79 Fitness (relative V.O2max) (mL/kg/min % predicted) 106.1 ± 15.9 97.1 ±23.3 .21 Mean arterial pressure (mmHg) 79 ± 5 82 ± 10 .34 Heart rate (bpm) 55.7 ± 5.8 59.3 ± 6.0 .10 Total cholesterol (mmol/L) 3.7 ± 0.9 3.9 ± 1.4 .86 HDL (mmol/L) 1.4 ± 0.2 1.4 ± 0.4 .92 Fasting glucose (mmol/L) 3.9 ± 0.4 3.9 ± 0.4 .81 CRP (mg/L) 2.3 ± 3.83 3.6 ± 3.5 .46 IL-6 (pg/mL) 8.6 ± 5.9 6.9 ± 3.5 .35 TNF-α (pg/mL) 16.5 ± 5.1 16.3 ± 2.8 .91 Table I Subjects' characteristics Values are mean ± SD unless indicated otherwise.BMI, Body mass index; bpm, beats per minute; CRP, C-reactive protein; Feno, fraction of exhaled nitric oxide; HDL, high-density lipoprotein; ICS, inhaled corticosteroid; LABA, long-acting beta-agonist; SABA, short-acting beta-agonist; TNF-α, tumor necrosis factor-alpha; V.O2, rate of oxygen consumption.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2015.02.033</identifier><identifier>PMID: 25913103</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Allergy and Immunology ; Asthma ; Asthma - physiopathology ; Blood pressure ; Case-Control Studies ; Cholesterol ; Endothelium, Vascular - physiopathology ; Exercise ; Female ; Humans ; Male ; Motor Activity ; Physical Fitness ; Surveys and Questionnaires ; Tumor necrosis factor-TNF ; Vascular Stiffness</subject><ispartof>Journal of allergy and clinical immunology, 2015-09, Vol.136 (3), p.809-811.e3</ispartof><rights>The Authors</rights><rights>2015 The Authors</rights><rights>Copyright Elsevier Limited Sep 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c553t-9518381d9bbf6f12c673b525964acab9be0a68b26e73f72d23bb654daa044c5d3</citedby><cites>FETCH-LOGICAL-c553t-9518381d9bbf6f12c673b525964acab9be0a68b26e73f72d23bb654daa044c5d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0091674915003395$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25913103$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moore, Linn E., BSc</creatorcontrib><creatorcontrib>Bhutani, Mohit, MD</creatorcontrib><creatorcontrib>Petersen, Stewart R., PhD</creatorcontrib><creatorcontrib>McMurtry, M. Sean, MD, PhD</creatorcontrib><creatorcontrib>Byers, Bradley W., BSc</creatorcontrib><creatorcontrib>Tedjasaputra, Vincent, MSc</creatorcontrib><creatorcontrib>Stickland, Michael K., PhD</creatorcontrib><title>Physical activity, fitness, and vascular health in patients with asthma</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>High levels of the proinflammatory cytokines IL-6, C-reactive protein, and tumor necrosis factor-alpha are elevated in asthma, and all are associated with increased CVD risk.2,3 Reduced endothelial vasodilation is seen in early stages of CVD development and is predictive of CVD.4 Patients with asthma have reduced endothelial function and increased arterial stiffness than do those without asthma.5,6 Systemic inflammation impairs endothelial function7 and increases arterial stiffness,8 but it is unknown whether there is a connection between systemic inflammation, vascular function, and arterial stiffness in subjects with asthma. Characteristic Control Asthma P value (2-tailed) Sample size, n (male/female) 16 (8/8) 16 (10/6) .72 Age (y) 26.6 ± 5.2 27.8 ± 6.1 .58 BMI (kg/m2) 24.7 ± 3.5 24.6 ± 4.6 .96 FEV1 prebronchodilator (% predicted) 96.3 ± 12.1 81.3 ± 15.1 .004 FEV1 postbronchodilator (% predicted) 100.9 ± 13.2 91.6 ± 12.6 .051 Feno (ppb) 17.9 ± 8.5 37.3 ± 40.9 .16 Asthma Control Questionnaire score 0.1 ± 0.2 1.0 ± 0.4 &lt;.001 Allergies (% yes) 18.8 57.1 .03 SABA usage (%) 0.0 56.3 &lt;.001 ICS usage (%) 0.0 18.8 &lt;.001 Combination ICS + LABA usage (%) 0.0 43.8 &lt;.001 Physical activity, steps/d 10,711 ± 2,675 11,125 ± 5,487 .79 Fitness (relative V.O2max) (mL/kg/min % predicted) 106.1 ± 15.9 97.1 ±23.3 .21 Mean arterial pressure (mmHg) 79 ± 5 82 ± 10 .34 Heart rate (bpm) 55.7 ± 5.8 59.3 ± 6.0 .10 Total cholesterol (mmol/L) 3.7 ± 0.9 3.9 ± 1.4 .86 HDL (mmol/L) 1.4 ± 0.2 1.4 ± 0.4 .92 Fasting glucose (mmol/L) 3.9 ± 0.4 3.9 ± 0.4 .81 CRP (mg/L) 2.3 ± 3.83 3.6 ± 3.5 .46 IL-6 (pg/mL) 8.6 ± 5.9 6.9 ± 3.5 .35 TNF-α (pg/mL) 16.5 ± 5.1 16.3 ± 2.8 .91 Table I Subjects' characteristics Values are mean ± SD unless indicated otherwise.BMI, Body mass index; bpm, beats per minute; CRP, C-reactive protein; Feno, fraction of exhaled nitric oxide; HDL, high-density lipoprotein; ICS, inhaled corticosteroid; LABA, long-acting beta-agonist; SABA, short-acting beta-agonist; TNF-α, tumor necrosis factor-alpha; V.O2, rate of oxygen consumption.</description><subject>Adult</subject><subject>Allergy and Immunology</subject><subject>Asthma</subject><subject>Asthma - physiopathology</subject><subject>Blood pressure</subject><subject>Case-Control Studies</subject><subject>Cholesterol</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Exercise</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Motor Activity</subject><subject>Physical Fitness</subject><subject>Surveys and Questionnaires</subject><subject>Tumor necrosis factor-TNF</subject><subject>Vascular Stiffness</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV2L1DAUhoMo7rj6B7yQgjdebLv5aNIGRJBF14UFF9TrcJKeMqmddkzSkfn3psyqsBd7FRKe93DyvIS8ZrRilKnLoRrA-YpTJivKKyrEE7JhVDelarl8SjaUalaqptZn5EWMA8130ern5IxLzQSjYkOu77bH6B2MBbjkDz4dL4repwljvChg6ooDRLeMEIotwpi2hZ-KPSSPU4rFb58fIKbtDl6SZz2MEV_dn-fkx-dP36--lLdfr2-uPt6WTkqRSi1ZK1rWaWt71TPuVCOszOuoGhxYbZGCai1X2Ii-4R0X1ipZdwC0rp3sxDl5d5q7D_OvBWMyOx8djiNMOC_RsIbRHBC6yejbB-gwL2HK22WKal4zVatM8RPlwhxjwN7sg99BOBpGzarZDGbVbFbNhnKTNefQm_vRi91h9y_y12sG3p8AzC4OHoOJLjtz2PmALplu9o_P__Ag7kY_rTX9xCPG__8wMQfMt7XotWcmaY5rKf4Ar2WhmA</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Moore, Linn E., BSc</creator><creator>Bhutani, Mohit, MD</creator><creator>Petersen, Stewart R., PhD</creator><creator>McMurtry, M. Sean, MD, PhD</creator><creator>Byers, Bradley W., BSc</creator><creator>Tedjasaputra, Vincent, MSc</creator><creator>Stickland, Michael K., PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20150901</creationdate><title>Physical activity, fitness, and vascular health in patients with asthma</title><author>Moore, Linn E., BSc ; Bhutani, Mohit, MD ; Petersen, Stewart R., PhD ; McMurtry, M. Sean, MD, PhD ; Byers, Bradley W., BSc ; Tedjasaputra, Vincent, MSc ; Stickland, Michael K., PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c553t-9518381d9bbf6f12c673b525964acab9be0a68b26e73f72d23bb654daa044c5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Allergy and Immunology</topic><topic>Asthma</topic><topic>Asthma - physiopathology</topic><topic>Blood pressure</topic><topic>Case-Control Studies</topic><topic>Cholesterol</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Exercise</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Motor Activity</topic><topic>Physical Fitness</topic><topic>Surveys and Questionnaires</topic><topic>Tumor necrosis factor-TNF</topic><topic>Vascular Stiffness</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, Linn E., BSc</creatorcontrib><creatorcontrib>Bhutani, Mohit, MD</creatorcontrib><creatorcontrib>Petersen, Stewart R., PhD</creatorcontrib><creatorcontrib>McMurtry, M. Sean, MD, PhD</creatorcontrib><creatorcontrib>Byers, Bradley W., BSc</creatorcontrib><creatorcontrib>Tedjasaputra, Vincent, MSc</creatorcontrib><creatorcontrib>Stickland, Michael K., PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, Linn E., BSc</au><au>Bhutani, Mohit, MD</au><au>Petersen, Stewart R., PhD</au><au>McMurtry, M. Sean, MD, PhD</au><au>Byers, Bradley W., BSc</au><au>Tedjasaputra, Vincent, MSc</au><au>Stickland, Michael K., PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physical activity, fitness, and vascular health in patients with asthma</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>136</volume><issue>3</issue><spage>809</spage><epage>811.e3</epage><pages>809-811.e3</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>High levels of the proinflammatory cytokines IL-6, C-reactive protein, and tumor necrosis factor-alpha are elevated in asthma, and all are associated with increased CVD risk.2,3 Reduced endothelial vasodilation is seen in early stages of CVD development and is predictive of CVD.4 Patients with asthma have reduced endothelial function and increased arterial stiffness than do those without asthma.5,6 Systemic inflammation impairs endothelial function7 and increases arterial stiffness,8 but it is unknown whether there is a connection between systemic inflammation, vascular function, and arterial stiffness in subjects with asthma. Characteristic Control Asthma P value (2-tailed) Sample size, n (male/female) 16 (8/8) 16 (10/6) .72 Age (y) 26.6 ± 5.2 27.8 ± 6.1 .58 BMI (kg/m2) 24.7 ± 3.5 24.6 ± 4.6 .96 FEV1 prebronchodilator (% predicted) 96.3 ± 12.1 81.3 ± 15.1 .004 FEV1 postbronchodilator (% predicted) 100.9 ± 13.2 91.6 ± 12.6 .051 Feno (ppb) 17.9 ± 8.5 37.3 ± 40.9 .16 Asthma Control Questionnaire score 0.1 ± 0.2 1.0 ± 0.4 &lt;.001 Allergies (% yes) 18.8 57.1 .03 SABA usage (%) 0.0 56.3 &lt;.001 ICS usage (%) 0.0 18.8 &lt;.001 Combination ICS + LABA usage (%) 0.0 43.8 &lt;.001 Physical activity, steps/d 10,711 ± 2,675 11,125 ± 5,487 .79 Fitness (relative V.O2max) (mL/kg/min % predicted) 106.1 ± 15.9 97.1 ±23.3 .21 Mean arterial pressure (mmHg) 79 ± 5 82 ± 10 .34 Heart rate (bpm) 55.7 ± 5.8 59.3 ± 6.0 .10 Total cholesterol (mmol/L) 3.7 ± 0.9 3.9 ± 1.4 .86 HDL (mmol/L) 1.4 ± 0.2 1.4 ± 0.4 .92 Fasting glucose (mmol/L) 3.9 ± 0.4 3.9 ± 0.4 .81 CRP (mg/L) 2.3 ± 3.83 3.6 ± 3.5 .46 IL-6 (pg/mL) 8.6 ± 5.9 6.9 ± 3.5 .35 TNF-α (pg/mL) 16.5 ± 5.1 16.3 ± 2.8 .91 Table I Subjects' characteristics Values are mean ± SD unless indicated otherwise.BMI, Body mass index; bpm, beats per minute; CRP, C-reactive protein; Feno, fraction of exhaled nitric oxide; HDL, high-density lipoprotein; ICS, inhaled corticosteroid; LABA, long-acting beta-agonist; SABA, short-acting beta-agonist; TNF-α, tumor necrosis factor-alpha; V.O2, rate of oxygen consumption.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25913103</pmid><doi>10.1016/j.jaci.2015.02.033</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2015-09, Vol.136 (3), p.809-811.e3
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_1710654397
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ScienceDirect Journals (5 years ago - present)
subjects Adult
Allergy and Immunology
Asthma
Asthma - physiopathology
Blood pressure
Case-Control Studies
Cholesterol
Endothelium, Vascular - physiopathology
Exercise
Female
Humans
Male
Motor Activity
Physical Fitness
Surveys and Questionnaires
Tumor necrosis factor-TNF
Vascular Stiffness
title Physical activity, fitness, and vascular health in patients with asthma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T18%3A43%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physical%20activity,%20fitness,%20and%20vascular%20health%20in%20patients%20with%20asthma&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Moore,%20Linn%20E.,%20BSc&rft.date=2015-09-01&rft.volume=136&rft.issue=3&rft.spage=809&rft.epage=811.e3&rft.pages=809-811.e3&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2015.02.033&rft_dat=%3Cproquest_cross%3E1710654397%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1709241646&rft_id=info:pmid/25913103&rft_els_id=S0091674915003395&rfr_iscdi=true